SI CEO exercises options for 10,000 shares
SHOULDER INNOVATIONS, INC. director and CEO Robert Joseph Ball exercised stock options to acquire 10,000 shares of Common Stock at $2.4804 per share.
Rhea-AI Filing Summary
SHOULDER INNOVATIONS, INC. director and CEO Robert Joseph Ball exercised stock options to acquire 10,000 shares of Common Stock at $2.4804 per share. Following the transaction, he directly holds 300,018 common shares.
His stock option position stands at 309,756 options after the exercise, with these options expiring on May 17, 2033. A footnote explains that his current share count includes 4,400 shares received from Cultivate MD Capital Fund I, LLC and 6,752 shares from Genesis Investment Holdings as in-kind distributions, in addition to the 278,866 shares previously reported as directly owned.
Positive
- None.
Negative
- None.
Insider Trade Summary
10,000 shares exercised/converted
Exercise
2 txns
Insider
Ball Robert Joseph
Role
CEO & Executive Chairman
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $2.4804 | $25K |
Holdings After Transaction:
Stock Option — 309,756 contracts (Direct);
Common Stock — 300,018 shares (Direct)
Footnotes (2)
- F1. Includes the following shares received without consideration as in-kind distributions: (i) 4,400 shares from Cultivate MD Capital Fund I, LLC; and (ii) 6,752 shares from Genesis Investment Holdings. In prior reports, the reporting person reported beneficial ownership of 278,866 shares of Shoulder Innovations common stock held directly.
- F2. The stock option vested as to one-fourth of the underlying shares on May 17, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter.
Key Figures
Options exercised: 10,000 shares
Exercise price: $2.4804 per share
Direct common shares held: 300,018 shares
+4 more
7 metrics
Options exercised
10,000 shares
Common Stock acquired via option exercise at $2.4804 per share
Exercise price
$2.4804 per share
Price for 10,000 Common Stock shares acquired through option exercise
Direct common shares held
300,018 shares
Direct Common Stock holdings after transaction
Options remaining
309,756 options
Stock options held after exercise, expiring May 17, 2033
In-kind distribution from Cultivate MD
4,400 shares
Common Stock received without consideration from Cultivate MD Capital Fund I, LLC
In-kind distribution from Genesis
6,752 shares
Common Stock received without consideration from Genesis Investment Holdings
Previously reported direct holdings
278,866 shares
Common Stock previously reported as directly owned in earlier filings
Key Terms
Stock Option, in-kind distributions, vested, beneficial ownership
4 terms
Stock Option financial
"The stock option vested as to one-fourth of the underlying shares on May 17, 2024"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
in-kind distributions financial
"Includes the following shares received without consideration as in-kind distributions"
vested financial
"The stock option vested as to one-fourth of the underlying shares on May 17, 2024"
beneficial ownership financial
"the reporting person reported beneficial ownership of 278,866 shares of Shoulder Innovations common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SI CEO Robert Joseph Ball do in this Form 4 filing?
Robert Joseph Ball exercised stock options to acquire 10,000 shares of SHOULDER INNOVATIONS common stock at $2.4804 per share. This increased his direct holdings to 300,018 common shares and reduced his option position to 309,756 options expiring in May 2033.
What stock option activity did the SI Form 4 report for Robert Joseph Ball?
The filing shows Ball exercised stock options covering 10,000 underlying common shares at an exercise price of $2.4804. After this exercise, he still holds 309,756 stock options, which are scheduled to expire on May 17, 2033, according to the transaction details in the form.
What is the exercise price and expiration for Robert Joseph Ball’s SI stock options?
The exercised options had an exercise price of $2.4804 per share for 10,000 underlying common shares. The remaining 309,756 options share the same grant structure and have an expiration date of May 17, 2033, as disclosed in the derivative transaction information.
How does this SI Form 4 characterize the nature of Robert Joseph Ball’s transactions?
Both transactions are coded “M,” indicating an exercise or conversion of derivative securities rather than open-market buying or selling. The filing’s transaction fields classify the direction as “acquire,” reflecting that Ball increased his direct common share ownership through option exercises.
AI-generated analysis. How Rhea-AI works. Not financial advice.
